Sihuan Pharmaceutical Holdings Stock Number Of Shares Shorted
Sihuan Pharmaceutical Holdings fundamentals help investors to digest information that contributes to Sihuan Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Sihuan Pink Sheet. The fundamental analysis module provides a way to measure Sihuan Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sihuan Pharmaceutical pink sheet.
Sihuan |
Sihuan Pharmaceutical Holdings Company Number Of Shares Shorted Analysis
Sihuan Pharmaceutical's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Sihuan Pharmaceutical Holdings has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The number of shares shorted for all United States stocks is 100.0% higher than that of the company.
Sihuan Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sihuan Pharmaceutical's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Sihuan Pharmaceutical could also be used in its relative valuation, which is a method of valuing Sihuan Pharmaceutical by comparing valuation metrics of similar companies.Sihuan Pharmaceutical is currently under evaluation in number of shares shorted category among its peers.
Sihuan Fundamentals
Return On Equity | -0.0487 | |||
Return On Asset | -4.0E-4 | |||
Profit Margin | (0.05) % | |||
Operating Margin | (0) % | |||
Current Valuation | 506.36 M | |||
Shares Outstanding | 9.33 B | |||
Shares Owned By Insiders | 55.02 % | |||
Shares Owned By Institutions | 4.21 % | |||
Price To Earning | 8.75 X | |||
Price To Book | 0.81 X | |||
Price To Sales | 0.41 X | |||
Revenue | 3.29 B | |||
Gross Profit | 2.45 B | |||
EBITDA | 914.73 M | |||
Net Income | 416.51 M | |||
Cash And Equivalents | 5.25 B | |||
Cash Per Share | 0.56 X | |||
Total Debt | 844.75 M | |||
Debt To Equity | 0.14 % | |||
Current Ratio | 2.43 X | |||
Book Value Per Share | 0.78 X | |||
Cash Flow From Operations | 665.29 M | |||
Earnings Per Share | 0.01 X | |||
Number Of Employees | 3.9 K | |||
Beta | 0.8 | |||
Market Capitalization | 1.2 B | |||
Total Asset | 14.5 B | |||
Retained Earnings | 5.54 B | |||
Working Capital | 4.66 B | |||
Current Asset | 6.17 B | |||
Current Liabilities | 1.51 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.02 % | |||
Net Asset | 14.5 B | |||
Last Dividend Paid | 0.014 |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Sihuan Pink Sheet
If you are still planning to invest in Sihuan Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sihuan Pharmaceutical's history and understand the potential risks before investing.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
CEOs Directory Screen CEOs from public companies around the world | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |